ArticleNPJ precision oncology2026

Genomic landscape and clinical impact of BRCA1/2 pathogenic variants in metastatic castration-resistant prostate cancer.

Kazuki Iida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.